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Abstract
The self-renewal capacity ascribed to hESCs is paralleled in cancer cell proliferation, suggesting that a common network of
genes may facilitate the promotion of these traits. However, the molecular mechanisms that are involved in regulating the
silencing of these genes as stem cells differentiate into quiescent cellular lineages remain poorly understood. Here, we show
that a differentiated cell specific miR-122 exemplifies this regulatory attribute by suppressing the translation of a gene,
Pkm2, which is commonly enriched in hESCs and liver cancer cells (HCCs), and facilitates self-renewal and proliferation.
Through a series of gene expression analysis, we show that miR-122 expression is highly elevated in quiescent human
primary hepatocytes (hPHs) but lost or attenuated in hESCs and HCCs, while an opposing expression pattern is observed for
Pkm2. Depleting hESCs and HCCs of Pkm2, or overexpressing miR-122, leads to a common deficiency in self-renewal and
proliferation. Likewise, during the differentiation process of hESCs into hepatocytes, a reciprocal expression pattern is
observed between miR-122 and Pkm2. An examination of the genomic region upstream of miR-122 uncovered hyper-
methylation in hESCs and HCCs, while the same region is de-methylated and occupied by a transcription initiating protein,
RNA polymerase II (RNAPII), in hPHs. These findings indicate that one possible mechanism by which hESC self-renewal is
modulated in quiescent hepatic derivatives of hESCs is through the regulatory activity of a differentiated cell-specific miR-
122, and that a failure to properly turn ‘‘on’’ this miRNA is observed in uncontrollably proliferating HCCs.
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Introduction
One of the hallmark traits ascribed to human embryonic stem
cells (hESCs) is a capacity for extensive self-renewal [1]. While the
indefinite cell division capacity of hESCs is an asset as an
unlimited source of pluripotent cells for use in tissue replacement,
the apparent similarity between stem cell self-renewal and cancer
cell proliferation has raised concerns over the tumorigenic risk of
hESCs and their derivatives in the transplanted tissue [2,3]. The
phenotypic parallels between these two classes of cells have raised
speculation that a common network of genes may be involved in
facilitating the promotion of these traits, and that a failure to
properly control the silencing of these genes in quiescent
derivatives of hESCs may give rise to uncontrolled proliferation
that is typical of many cancer cells. However, to date, the
molecular mechanisms that involved in governing the regulation of
this shared network of genes in hESCs and cancer cells remain
poorly understood.
Although both hESCs and cancer cells possess an extensive cell
division capacity that gives rise to identical progenies, unlike
cancer cell proliferation, stem cell self-renewal is tightly regulated
by extrinsic signals and intrinsic factors in the developing embryo
[4–7]. During development, the transition from pluripotent to
lineage specified cells is carefully orchestrated by turning on genes
that are required for the specification of lineage determining cells
and restricting the expression of genes that promote self-renewal
[8,9]. As stem cells move further along the differentiation pathway
toward various cell fate lineages, many differentiated cell types
enter a quiescent or terminally differentiated state by exiting the
cell cycle. This is especially evident during liver morphogenesis
when stem cells differentiate into quiescent hepatocytes. While
much attention has been focused on elucidating the mechanisms
that are involved in promoting ESC self-renewal, less attention has
been given to understanding how this trait is down-regulated as
hESCs differentiate into quiescent cell types, and whether a failure
to properly turn ‘‘on’’ these regulatory mechanisms can be
observed in proliferating cancer cells.
In this study, we have examined the role of a differentiated cell-
specific miR-122 as a regulator of a common network of genes that
promote the facilitation of stem cell self-renewal as well as
hepatocellular carcinoma cell (HCC) proliferation. microRNAs
(miRNAs) are endogenous regulatory RNAs that refine and limit
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translation, and influencing the ultimate proteome [10]. Even
though the number of miRNAs in the human genome is small
relative to the number of protein coding genes, this family of
RNAs has been described as one of the master regulators of the
cell, because of their involvement in a wide range of cellular or
organ programs including, for example, maintaining stemness,
guiding differentiation, and functioning as tumor suppressors or
oncomirs depending on the cell type in which they are expressed
[11–15]. In the liver, miR-122 has been described as a critical
facilitator of various homeostatic functions, notably, fatty acid and
cholesterol metabolism, as well as hepatitis C viral replication [16–
20]. Of relevance to this study are recent reports demonstrating
the role of miR-122 as a potential tumor suppressor, because of its
ability to regulate cell cycle progression and metastasis in liver
cancer cells [21–27]. The ability of miR-122 to inhibit cell cycle
progression in liver cancer cells raises the possibility that this
miRNAs may also regulate hESC cell self-renewal during
hepatocyte differentiation, by suppressing a common network of
genes that promote hESC self-renewal as well as HCC
proliferation.
Here, we show that miR-122 is highly enriched in differentiated
human primary hepatocytes (hPHs), and functions as a modulator
of hESCs self-renewal and HCC proliferation by suppressing the
translation of a metabolic protein, PKM2. Through a series of
global gene expression analysis, we show that miR-122 expression
is either lost or severely attenuated in hESCs and HCCs, while an
opposing expression pattern is observed for Pkm2. Both depleting
hESCs and HCCs of Pkm2, or gain of miR-122 function, leads to a
notable deficiency in self-renewal and proliferation. Likewise,
during the differentiation process of hESCs into hepatocytes, a
reciprocal expression pattern is observed between miR-122 and
Pkm2, suggesting a possible role for this miRNA as a modulator of
self-renewal during hepatic lineage specification. An examination
of the genomic region up-steam of miR-122 uncovered hyper-
methylation in hESCs and HCCs, while the same region is de-
methylated and occupied by a transcription initiating protein,
RNA polymerase II (RNAPII), in hPHs. Our findings suggest that
one possible mechanism by which hESC self-renewal and HCC
proliferation are modulated is through the regulatory activity of a
differentiated cell-specific miR-122, which directly suppresses the
translation of a gene, Pkm2, that is commonly enriched in hESCs
and HCCs, and plays a role as a facilitator of these traits.
Results
mRNAs that are commonly enriched in hESCs and HCCs
possess Gene Ontology (GO) functional terms describing
actively dividing cells
As a starting point of our study, we sought to determine whether
the similarity between hESC self-renewal and HCC proliferation is
reflected in the functional properties of mRNAs that are
commonly enriched in these classes of cells. To do this, we
performed a series of global mRNA expression profiles in hESCs,
hPHs and HCCs (HepG2 and Hep3B), and compared their
expression patterns. We show using hierchical clustering and
Pearson correlation analyses that global gene expression patterns
within each cell class are highly similar, while notable differences
are observed among the three classes of cells (Figure 1A–C). These
observations indicate that hESCs, hPHs and HCCs possess gene
expression signatures that are specific and unique for each class of
cells. Pearson correlation further revealed that while a large
dissimilarity exists between the correlation coefficients undifferen-
tiated hESCs and differentiated hPHs (mean r
2=0.5441), HCCs
appear to possess a signature that resembles ESCs (mean
r
2=0.6258) as well as hPHs (mean r
2=0.6570), relative to the
correlation between hPHs and hESCs (Figures 1B and 1C). These
observations led us to speculate whether a large fraction of genes
that are commonly enriched in HCCs and hPHs may reflect a
common tissue origin, while genes that are commonly enriched in
HCCs and hESCs may possess functional relevance to self-renewal
and proliferation. In order to evaluate this, the normalized data
generated from the mRNA arrays were log2-transformed, and
categorized as ‘‘enriched’’ based on a parameter set at log2 value
of 7.0 or higher. For HCCs, genes were considered ‘‘enriched’’ if
both HepG2 and Hep3B cells met the enrichment criteria. We
found that among the 17,172 mRNAs that were evaluated, 367
(2.14%) were commonly enriched in hESCs and HCCs, but not in
hPHs, and 249 (1.45%) were commonly enriched in hPHs and
HCCs, but not in hESCs (Figure 1D). To evaluate the functional
properties of these sets of genes, the program DAVID [28] was
utilized to assess the functional classification of each gene based on
Gene Ontology (GO) descriptions. GO classifications were then
evaluated further using a feature in DAVID which permits the
clustering these genes according to the similarity of their functional
terms. Not surprisingly, we found that a large fraction of the gene
set that is commonly enriched in hESCs and HCCs generated GO
clusters describing functional activities that are highly relevant for
actively dividing cells (e.g., M phase, DNA replication, DNA
replication initiation, regulation of cell cycle, and chromosome
segregation) (Figure 1D, highlighted in red). In contrast, mRNAs
commonly enriched in HCCs and hPHs, but not in hESCs,
generated generated clusters describing functions that are
generally associated with the homeostasis of differentiated cells
(e.g., response to external stimulus, response to wounding, and
immune and inflammatory responses), and various functions
relating to the liver (e.g., reverse cholesterol transport and lipid
metabolic process) (Figure 1D). Taken together, these results show
that a large fraction of mRNAs that are commonly up-regulated in
both hESCs and HCCs, but not in hPHs, embody GO functional
descriptions that reflect the self-renewal and proliferation traits
ascribed to stem cells and cancer cells.
Differentiated cell-specific miR-122 is highly expressed in
hPHs, and predicted to target a hepatic progenitor stem
cell associated gene, Pkm2, that is commonly enriched in
hESCs and HCCs
Because mRNAs commonly up-regulated in hESCs and HCCs
embody GO functional descriptions associated with self-renewal
and proliferation, we sought to determine whether a differentiated
cell-specific miR-122 facilitates the suppression of these traits in
hESCs and HCCs by targeting mRNAs commonly up-regulated
in these two classes of cells. To do this, we performed global
miRNA expression profiles on hESCs, HCCs and hPHs to
determine whether miR-122 is highly expressed in hPHs, but
attenuated in hESCs and HCCs. By using this approach, we
identified seven miRNAs, including miR-122, that are exclusively
enriched in hPHs (Figure 2A). We then utilized miRNA target
prediction tools provided by miRNAMap 2.0 [29] and Target
Scan [30] to examine whether these seven miRNAs contain seed
sequences that are predicted to target the 39UTR of the 367
mRNAs that are commonly enriched in hESCs and HCCs
(Figure 1D and Figure 2B). Our analysis uncovered 18 out of 367
mRNAs that are predicted to be targeted by at least one of the
seven hPH-specific miRNAs (Figure 2C and 2D). In this list, we
observed that miR-122 is predicted to target three genes (Ndrg3,
Npepps, Pkm2). Among this list of genes that are predicted to be
miRs in hESC Self-Renewal and HCC Proliferation
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depth analysis, because the embryonic isoform of pyruvate kinase
(Pkm2) is reported in the literature to be highly expressed in
actively proliferating hepatic progenitor stem cells (hepatoblasts),
as well as many cancer cells [31–34]. An examination of the
39UTR of Pkm2 using Target Scan and miRNAMap 2.0 revealed
two potential binding sites for miR-122 (Figure 2E). We, therefore,
speculated that Pkm2 may facilitate the promotion of hESC self-
renewal and HCC proliferation, and that miR-122 may play a role
as a modulator of these traits in differentiated hepatocytes by
suppressing the translation of Pkm2.
hPH-specific miR-122 suppresses the translation of Pkm2
To determine whether miR-122 is capable of attenuates the
expression of Pkm2 in vitro, we first validated the opposing
expression patterns of Pkm2 and miR-122 in hESCs, HCCs and
hPHs, using quantitative real time PCR (RT-qPCR). In addition
to these cell types, telomerase-immortalized human fetal hepato-
cytes (hFHs) were evaluated as a representative sample of hepatic
progenitor stem cells – during liver morphogenesis, actively
proliferating fetal hepatocytes give rise to quiescent mature
hepatocytes. The RT-qPCR results were consistent with the
mRNA expression array data, and showed an elevated Pkm2
expression in hESC and HCCs, while in hPHs, Pkm2 was severely
attenuated (Figure 3A). An opposite expression pattern was
observed for miR-122 in these cell types (Figure 3B). As expected,
hFHs mirrored the Pkm2 and miR-122 expression patterns that
were observed in hESCs and HCCs.
Because established cell lines cannot fully recapitulate clinical
malignancy, we also examined the enrichment pattern of miR-122
in primary liver tissues from three patients. Consistent with the
observations in HCCs, we found that miR-122 expression was
Figure 1. mRNA enrichment patterns and GO analysis in hESCs, HCCs and hPHs. (A) The cluster dendogram shows the similarity of mRNA
expression patterns within each cell class, while marked differences exist among stem cells (green), cancer cells (red) and differentiated hepatocytes
(blue). The scale on the X axis displays the level of differences among the samples based on Pearson correlation using a 1-r distance measure. (B)
Pearson correlation computation of all the samples. Coefficient values within the same color scheme distinguishes the classes of cells that were
correlated: ESCs vs. ESCs (green), ESCs vs. HCCs (brown), ESCs vs. hPHs (dark green), HCCs vs. HCCs (orange), HCCs vs. hPHs (purple) and hPHs vs.
hPHs (blue). (C) Average correlation values from each color category from Figure 1B. (D) The data generated from the mRNA expression arrays were
normalized, log2-transformed, categorized as ‘‘enriched’’ based on an enrichment parameter set at log2 value of 7.0 or higher. The enriched genes are
distributed according to the Venn diagram. The three circles represent hESCs (green), hPHs (blue), and HCCs (orange). GO functional annotation
clusters were derived from mRNAs that were commonly enriched in HCCs and hESCs (367), and HCCs and hPHs (249). The clusters were ranked
according to the EASE scores of each term, and the top 20 clusters are listed in the tables. For each cluster, the GO term with the lowest P-value is
shown as a representative functional term. The columns list the cluster ID, the enrichment score, GO ID of each term, P-value, fold enrichment, and
the false discovery rate (FDR) of each term. Boxed in red are GO terms describing cell cycle regulation.
doi:10.1371/journal.pone.0027740.g001
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These results indicate that miR-122 expression is pervasively
attenuated in self-renewing hESCs and proliferating liver cancer
cells, and espouses an opposing expression pattern to Pkm2.
We then performed a series of tests using a luciferase reporter
vector to evaluate whether miR-122 hybridizes to the in silico
predicted sites in the 39UTR of Pkm2 and inhibit translation
(Figure 2E). To do this, a portion of the 39UTR of Pkm2
containing either of the two predicted miR-122 target sequences,
and two derivative sequences with three-mismatch mutations,
were cloned into separate luciferase reporter vectors (Figure 3D).
Each of these vectors was then co-transfected into HepG2 cells
with precursor miR-122 molecules or mock precursor miR
molecules. The cells were assayed for luciferase activity 36 hours
post-transfection. We found that HepG2 cells that were transfected
with either of the two wild-type luciferase constructs resulted in a
significant reduction of the luciferase activity in the presence of
precursor miR-122 relative to the control (Figures 3E and 3F).
Suppression of the luciferase activity was not observed when
precursor miR-122 was co-transfected into HepG2 cells with
luciferase constructs that contained the three-base mismatch
mutation. These data indicate that miR-122 directly binds to the
two predicted target sites in the 39UTR of Pkm2 and suppresses
translation. Protein immunoblot assay validated the direct
translational suppression of Pkm2 by miR-122 (Figure 3G).
To ascertain the endogenous translational suppression of Pkm2
by miR-122, we performed a series of loss-of-function analyses by
ectopically transfecting HepG2 and Hep3B cells with siPkm2,
precursor miR-122 molecules, or mock precursor miR molecules.
The transfected cell cultures were assayed 36 hours later for the
level of Pkm2 expression using RT-qPCR. Consistent with the
luciferase reporter assays, over-expression of miR-122 in HepG2
and Hep3B cells significantly reduced the level of Pkm2 transcripts
relative to the mock miR transfections (Figure 3H), indicating that
Figure 2. miRNA enrichment pattern and the predicted target mRNAs. (A) The data generated from the miRNA arrays were normalized, log2-
transformed, categorized as ‘‘enriched’’ based on an enrichment parameter set at log2 value of 6.0 or higher, and distributed according to the Venn
diagram. For HCCs, genes were considered enriched if both HepG2 and Hep3B cells met the enrichment criteria. The three circles in the Venn diagram
represent the number of enriched gene sets in hESCs (green), hPHs (red), and HCCs (blue). Based on this criteria, seven miRNAs were identified to be
exclusively enriched in hPHs. (B) mRNA enrichment pattern as shown in Figure 1. (C) miRNAs that were exclusively enriched in hPHs are listed in the
first column. The second column lists 18 mRNAs that were commonly enriched in hESCs and HCCs, and predicted to be targeted by hPH-specific
miRNAs (Figure 2A) based on both Target Scan and miRNAMap 2.0. (D) Enrichment pattern and hierarchical clustering of mRNAs that are predicted to
be targeted by hPH-specific miRNAs from Figure 2C. Gene symbols are listed along the right column of the heatmap. The scale bar across the top
depicts standard deviation change from the mean. (E) Predicted duplex formation between miR-122 and Pkm2 39UTR based on miRNAMap and
Target Scan. The lower Mfe values reflect the energetically more probable hybridizations between the miRNAs and the target genes. The seed
sequences are conserved between Homo sapiens (H), Pan paniscus (P) and Mus musculus (M). Additional conservation information and the genomic
locations of miR-122 and the 39UTR of Pkm2 are shown in Figures S1 and S2.
doi:10.1371/journal.pone.0027740.g002
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destabilization. These results suggest that an absence of miR-122
expression in hESCs and HCCs may permit an increased
expression of Pkm2. In contrast, the high level of miR-122
expression in hPHs likely attenuates the endogenous Pkm2
expression.
Pkm2 facilitates the promotion of hESC self-renewal and
HCC proliferation
To determine whether Pkm2 facilitates the promotion of hESC
self-renewal and HCC proliferation, we performed a series of in
vitro loss-of-function analysis by silencing the expression of Pkm2 or
over-expressing miR-122 in these cells. To do this, we transfected
HepG2 and Hep3B cells with siPkm2, precursor miR-122
molecules, or mock control miR molecules, and evaluated the
culture for cellular proliferation 36 hours following the transfec-
tion procedure using an MTT based assay. Compared to the
control, cells that were treated with siPkm2 or precursor miR-122
molecules yielded approximately 10–15% lower absorbance at
570 nm (Figure 4A). Hoechst stained images of HepG2 and
Hep3B cells at 24 and 36 hours post-transfection showed a notable
difference in the amount of nuclei between the control, and both
the siPkm2 and precursor miR-122 transfected conditions
(Figures 4B and 4C). Quantification of the Hoechst stained nuclei
from randomly chosen regions of the cultures validated the
proliferation deficiency in the siPkm2 and miR-122 transfected
Figure 3. miR-122 hybridizes to the 39UTR of Pkm2 and induces endogenous translation suppression. (A) RT-qPCR of Pkm2 expression in
hESCs, hPHs, HepG2, Hep3B and hFHs. (B) RT-qPCR of miR-122 expression in hESCs, hPHs, HepG2, Hep3B and hFHs. (C) RT-qPCR of miR-122
expression in human liver tumor samples relative to the normal tissue counterparts. (D) Outline of the luciferase reporter construct for validating the
interaction of miR-122 with the two overlapping target sites within the 39UTR of Pkm2. miRNA response elements (MREs) that were predicted by
miRNAMap (WT#1) (chr15:70,278,510–70,278,528) and both miRNAMap and Target Scan (WT#2) (chr15:70,278,518–70,278,545) as shown in Figure 2E
were inserted into separate miR-REPORT vectors, immediately downstream of the Firefly luciferase gene, which is under the control of a constitutive
CMV promoter. Downstream of MRE insert is polyadenylation signal (pA). The overlapping target sequences are colored in gray. In the mutant
reporter constructs of WT#1 and WT#2 (MUT#1 and MUT#2), a three-basepair mismatch mutation (red, underlined) was introduced into the seed
region. Reporter constructs as these are a standard method used to provide experimental evidence that miRNAs can directly repress translation
initiation. (E, F) Each Firefly luciferase construct was cotransfected with precursor miR-122 molecules or mock miRNA molecules into HepG2 cells, and
assayed for Firefly luciferase activity after 36 hours. Renilla luciferase construct was used as a normalization tool. The bar graphs show a decrease in
luciferase activity when the cells were cotransfected with the wild-type (WT#1o rW T #2) MREs and precursor miR-122 molecules compared to the
mock control. The difference in luciferase activity was not observed in mutant MREs (MUT#1 or MUT#2). (G) Detection of PKM2 by Western blot
assay in HepG2 and Hep3B cells 3 days after transduction with lentivirus over-expressing miR-122 (miR-122) or scambled oligo sequence as control
(C). (H) A decreased level of Pkm2 transcripts was observed 36 hours after transfecting the HepG2 and Hep3B cells with either siPkm2 or precursor
miR-122 molecules compared to the control cells that were transfected with mock miRNA molecules. For all statistical analyses, n=3; error bars
represent s.e.m.; Student’s t-test results are indicated by (*) P,0.05 and (**) P,0.01 relative to the control.
doi:10.1371/journal.pone.0027740.g003
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hESCs were transfected with siPkm2, precursor miR-122 mole-
cules, or mock control miR molecules, we observed, in general, a
more frequent occurrence of smaller sized colonies in the siPkm2
and miR-122 transfected conditions compared to the control
(Figure 4D). In addition, the morphology of a larger fraction of
hESC colonies in the miR-122 transfected condition appeared
differentiated/unhealthy (Figure 4D and 4E). To examine the
effect of knocking-down Pkm2 and over-expressing miR-122 on
hESC pluripotency, we assayed the expression patterns for hESC
markers (Pou5f1, Nanog, Sox2) (Figure 5F), mature hepatocyte
markers (Alb, a1At, Tf) (Figure 4G), and early differentiation
markers following the transfection procedure (Sox17, Brach, Gsc,
Cxcr4, Foxa2, Mixl1) (Figure 4H). We observed that hESCs that
were transfected with siPkm2 maintained similar expression levels
of these genes relative to the control. In contrast, hESCs that were
transfected with precursor miR-122 molecules revealed an
increased expression of one of the stem cell markers (Sox2), as
well as one of the early differentiation markers (Gsc). The markers
for mature hepatocytes (Alb, a1At, Tf) did not show a statistically
significant difference compared to the control when hESCs were
transfected with siPkm2 or miR-122 precursor molecules. These
findings suggest that over-expressing miR-122 or knocking-down
Pkm2 in hESCs and HCCs modulates self-renewal and prolifer-
ation. However, while knocking-down Pkm2 did not affect the ESC
pluripotency associated genes that were observed, keeping the
differentiated cell-specific miR-122 attenuated in hESCs appears
essential in order to prevent the destabilization of a ESC marker
genes, Sox2, and also, to inhibit the induction of an early
differentiation gene, Gsc.
Figure 4. Reduction of endogenous Pkm2 expression by miR-122 modulates cellular proliferation. (A) HepG2 and Hep3B cells were
transfected with siPkm2, precursor miR-122 molecules, or mock miRNA molecules, and evaluated for cellular proliferation using an MTT based assay
36 hours post-transfection. n=3; error bars represent s.e.m.; Student’s t-test results are indicated by (*) P,0.05 and (**) P,0.01 relative to the control.
(B,C) HepG2 and Hep3B cells were transfected with siPkm2, precursor miR-122 molecules, or mock miRNA molecules and stained with Hoecht
24 hours (4B) or 36 hours (4C) post-transfection. (D) Feeder dependent hESCs were transfected with siPkm2, precursor miR-122 molecules, or mock
miRNA molecules. 36 hours post-transfection the morphology of the cells were observed. In general, smaller hESC colonies were observed when
transfected with siPkm2 compared to the control. hESCs that were transfected with miRNA-122 molecules showed more colonies with
morphologically differentiated regions (shown by red arrows). (E) Feeder independent hESCs transfected with mock miRNA molecules showed tight
cell arrangement, while hESCs transfected with miR-122 frequently showed lose and unhealthy cellular morphology. Green boxes show enlarged
images. (F,G,H) RT-qPCR of feeder independent hESCs transfected with siPkm2, precursor miR-122 molecules, or mock miRNA molecules showed no
significant change in Pou5f1 and Nanog expression compared to the control (4F). A significant increase in Sox2 expression was observed in hESCs that
were transfected with precursor miR-122 molecules. No significant change in mature hepatocyte markers (Alb, a1At and Tf) was observed (4G). RT-
qPCR of early hepatic lineage markers revealed a significant increase in GSC expression when hESCs were transfected with precursor miR-122
molecules (4H). n=3; error bars represent s.e.m.; Student’s t-test results are indicated by (*) P,0.05 and (**) P,0.01 relative to the control.
doi:10.1371/journal.pone.0027740.g004
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and miR-122 during hepatocyte differentiation of hESCs
During the lineage specification process of hESCs into
hepatocytes, the narrowing of the pluripotent potential is
accompanied by a gradual loss of self-renewal. By the time stem
cells have differentiated into mature hepatocytes, the cells are no
longer self-renewing, and have settled into a quiescent state. Given
the high enrichment of Pkm2 in rapidly self-renewing hESCs and
proliferating HCCs, and the role of miR-122 as a direct suppressor
of this gene, we asked whether the loss of self-renewal during the
hepatocyte differentiation process may be accompanied by a
decreased Pkm2 expression, and a corresponding increased
expression of miR-122. To evaluate this, we utilized a three-step
in vitro differentiation method for directing the specification of a
large fraction of hESCs into hepatocyte-like cells [35–37], and
examined the expression patterns of Pkm2 and miR-122 at 5 day
intervals during the differentiation timeline. To verify the efficacy
of the differentiation method, we confirmed the gradual down-
regulation of hESC associated genes (Pou5f1, Nanog, and Sox2)
(Figures 5A–C), and the up-regulation of mature hepatocyte
markers (Alb, a1At, and Tf) (Figures 5D–F) during the same 5 day
intervals using RT-qPCR. In addition, we also confirmed the
presence of definitive endoderm (DE) at day 5 of our differenti-
ation timeline, which recapitulates the gastrulation process in the
developing embryo, and gives rise to hepatic and pancreatic
progenitor cells [37] (Figure 5G). Our results show that after day 5,
the level of Pkm2 expression began to decrease (Figure 5H). As
stem cells moved further along the differentiation pathway, Pkm2
expression continued to decrease with a corresponding increase in
miR-122 expression. At day 30 of the differentiation timeline when
a large fraction of hESCs have differentiated into mature
haptocyte-like cells, a low level of Pkm2 expression was observed.
Figure 5. Pkm2 and miR-122 expression patterns are inversely correlated during hepatic differentiation of hESCs. (A–C) RT-qPCR of
hESC associated marker genes –Pou5f1, Nanog and Sox2– at 5 day intervals during the differentiation timeline, relative to day 0. n=3; error bars
represent s.e.m. Student’s t-test results are indicated by (*) P,0.05 and (**) P,0.01 relative to hESCs (day 0). (D–F) RT-qPCR of mature hepatocyte
marker genes –Alb, a1At and Tf– at 5 day intervals during the differentiation timeline, relative to day 0. n=3, error bars represent s.e.m. Student’s t-
test results are indicated by (*) P,0.05 and (**) P,0.01 relative to hESCs (day 0). (G) RT-qRCR of genes reported to be up-regulated (Cxcr4, Gsc, Sox17,
Foxa2, Mixl1) and down-regulated (Brach) in definitive endoderm. Solid bars represent the relative mRNA expression of hESCs. Dotted bars represent
the relative mRNA expression of embryoid bodies (EBs) that were not treated with Activin A recombinant protein (Activin A induces definitive
endoderm). Checkered bars represent the relative mRNA expression of EBs that were treated with Activin A recombinant protein to induce definitive
endoderm cells. n=3; error bars represent s.e.m. Student’s t-test results are indicated by (*) P,0.05 and (**) P,0.01, relative to hESCs. (H) Relative
levels of Pkm2 expression compared to miR-122 expression via RT-qPCR at 5 day intervals during the differentiation timeline of hESCs into mature
hepatocytes, relative to day 0 (undifferentiated hESCs). The diagram in between the two graphs describes the differentiation method corresponding
to the differentiation timeline.
doi:10.1371/journal.pone.0027740.g005
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observed in hESCs. We suspect that at this may reflect a
heterogeneous population of cells in the culture condition,
composed of mature hepatocyte-like cells, as well as some
remaining hepatic and other progenitor stem cells. Overall, these
observations show that a reciprocal expression exists between Pkm2
and miR-122 during hepatic lineage specification of hESCs. These
findings suggest a role for miR-122 as a potential modulator of
hESC self-renewal during the hepatocyte differentiation process by
suppressing the translation of Pkm2.
The up-stream genomic region of miR-122 is occupied by
RNAPII in hPHs but hyper-methylated in hESCs and HCCs
In the preceding sections, we have shown that attenuating the
expression of miR-122 in hESCs and HCCs allows for a
constitutive expression of Pkm2, which in turn, facilitates the
promotion of self-renewal and proliferation in these cells. We,
therefore, sought to understand the molecular mechanism that
may be involved in regulating the expression of this miRNAs in
hESCs, HCCs and hPHs. To do this, we examined the 20 kb
genomic region up-stream of miR-122, where the putative
promoter sequence of this miRNA is likely to be found, for
methylation status and binding activity of RNA Polymerase II
(RNAPII) in hESCs, HCCs and hPHs. We chose to focus our
attention on these epigenetic factors to because: 1) RNAPII has
been described in the literature as the most prominent miRNA
transcription initiating polymerase in metazoans [38]; and 2)
hyper-methylation of the promoter region of genes has been
reported to be frequently observed in aberrant gene silencing in a
multitude of cancer cells [39]. We utilized a chromatin
immunoprecipitation (ChIP) assay to examine the RNAPII
binding activity and DNA methylation status of the 20 kb region
upstream of the mature miR-122 sequences in the genomes of
hESCs, hPHs and Hep3B. The ChIP data revealed that the
upstream region of miR-122 in hPHs was covered with RNAPII,
while in hESCs and Hep3B cells, the same region was hyper-
methylated (Figure 6A). To verify these findings, we designed two
PCR primer sets using templates from two separate regions
(Chr18:54,264,000–54,265,000 and Chr18:54,268,000–54,269,000)
that appeared to be hyper-methylated in hESCs and HCCs, and
assayed for the presence of RNAPII and 5-MeC in chromatin
immunoprecipitates of hESC, hPH and HCCs (Figures 6B and 6C).
These experiments validated hypo-methylation and the presence of
RNAPII in hPHs and hyper-methylation in HCCs and hESCs. To
determine whether these regions contain a putative promoter
sequence for miR-122, two programs, Promoter 2.0 [40] and BDGP
[41], designed to identify possible promoter sequences in the genome
were utilized. Both Promoter 2.0 and BDGP revealed a high
likelihoodthattheregionbetween54,264,000–54,265,000maycontain
a possible promoter sequence (Figure 6A; Figures S4A–C). We,
therefore, performed additional experiments using bisulfite
treatment of hESCs, HCCs and hPHs to validate whether this
genomic region is hyper-methylated in hESCs and HCCs, while
hypo- methylation in hPHs. By using PCR primers designed to
amplify either the methylated or unmethylated regions of DNA
after bisulfite treatment (Figure 6D), we show that the predicted
promoter region of miR-122 is methylated in hESCs and HCCs,
but unmethylated in hPHs (Figure 6E). We verified this finding
using primers designed by the program MethPrimer program
[42], which also showed that the predicted promoter region of
miR-122 is unmethylated in hPHs, but methylated in hESCs and
HCCs (Figures 7A–C). To confirm whether the promoter of miR-
122 is located in this region, 59RACE was performed to
determine the transcription start site (TSS). By using this
approach, we show that the TSS is located within the predicted
promoter region of miR-122. In addition, the CCAAT-box and
TATA-box are found at the upstream region of this TSS, which
is frequently observed in the promoters many genes regulated by
RNAPII (Figures 8A, B). Hence, the combined results of ChIP-
chip, bisulfite sequencing, and 59RACE analyses suggest that in
hPHs, RNAPII binds to the hypo-methylated promoter of miR-
122 and initiates transcription. In contrast, hyper-methylation of
the same genomic region appears to prevent the binding of this
transcription factor in hESCs and HCCs, andinhibits the
transcription of this miRNA. In order to verify these findings in
vitro, we treated the HepG2 and Hep3B cells with a demethyl-
ating reagent, 5-Aza-29Deoxycytidine (5-aza-dC), and performed
RT-qPCR 72 hours following the treatment to measure the level
of miR-122 expression. We found that in HCCs that were treated
with 5-aza-dC, a significant increase in miR-122 expression was
observed compared to the control (Figures 8C and 8D).
Moreover, we observed a decreased expression of Pkm2 in the
same conditions (Figures 8E and 8F). These findings suggest that
miR-122 expression in hESCs, HCCs and hPHs may be
associated with the methylation status and RNAPII binding
activity at the promoter region of this gene (Figure 9).
Discussion
The present work has provided evidence to suggest the
involvement of a differentiated cell-specific miR-122 as a
m o d u l a t o ro fh E S Cs e l f - r e n e w a la n dH C Cp r o l i f e r a t i o n
through a direct translational suppression of a gene, Pkm2,
that is commonly enriched in these classes of cells. Both loss of
Pkm2 and gain of miR-122 function in hESCs and HCCs lead
to a severe deficiency in self-renewal and proliferation, and
during the differentiation process of hESCs into hepatocytes, a
reciprocal expression pattern is observed between miR-122 and
Pkm2. These findings suggest a possible role for miR-122 as a
modulator of self-renewal during hepatic lineage specification,
and that a failure to properly attenuate the expression of this
miRNA is observed in proliferating HCCs. An examination of
the genomic region up-steam of miR-122 uncovered hyper-
methylation in hESCs and HCCs, while the same region is de-
methylated and occupied by a transcription initiating protein,
RNA polymerase II (RNAPII) in hPHs. Our findings suggest
that hyper-methylation of the genomic region up-stream of
miR-122 may interfere with the binding of RNAPII, which in
turn, inhibits a proper initiation of miR-122 transcription
(Figure 9). The coordinated interplay between miR-122 and
Pkm2 suggests a novel and elegant mechanism for controlling
the expression of a gene that may be beneficial for stem cells,
but becomes undesirable as stem cells transition into a
differentiated quiescent hepatic cell fate. By initiating the
expression of miR-122, the differentiating cells of a hepatic
l i n e a g eh a v ee v o l v e da ne f f e c t i v em e t h o df o rr e d u c i n gt h ec e l l
of a transcript that they have outgrown, in order to pave a path
to ushering in a new phenotype for which self-renewal is
undesired. A failure to elevate the expression of miR-122 is
observed in hepatocellular carcinoma cells, and its effect on
cellular proliferation suggests that miR-122 embodies a
function that is reminiscent of a tumor suppressor.
The activation of a specific metabolic pathway involving the
enzyme pyruvate kinase (PK) in highly proliferating cancer cells
has been described decades ago by Otto Warburg [43] – a
metabolic process that is now known as aerobic glycolysis or the
Warburg effect [44]. Since the initial discovery, various studies
have shown that while Pkm2 expression is primarily elevated in
miRs in hESC Self-Renewal and HCC Proliferation
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terminally differentiated hepatocytes, PK is altered into a
different isozyme, PK-L. Recent studies have demonstrated that
in several cancer cells, the primary Pkm2 transcript is re-
expressed, however, in an altered isoform that is capable of
interacting with a phosphor-tyrosine (pTyr) motif, which enables
these cells to redirect oxidative phosphorylation towards aerobic
glycolysis for growth and proliferation [5,45,46]. The ramifica-
tions of these findings are significant in reference to this study, as
they suggest that in differentiated normal hepatocytes, miR-122
may function as a critical tumor suppressor by negatively
regulating the level of Pkm2 transcripts in the cell, thereby
minimizing the likelihood that PKM2 may interact with pTyr.
Hence, in addition to the many homeostatic functions that have
been ascribed to miR-122 in the liver, this miRNA may also
function as an early defense mechanism against a possible
neoplastic transformation.
It remains to be seen whether silencing miR-122 in terminally
differentiated hepatocytes may give rise to tumorigenesis. Such
analysis is hampered at present by the lack of experimental
strategy for keeping hPHs stable and/or alive for more than a few
days after the isolation procedure from the cadaveric liver or
hepatic resections, and the lack of techniques to identify, isolate,
and culture mature hepatic derivatives from hESCs in vitro.
Although several studies have knocked-down miR-122 expression
in the mouse liver using ‘antagomirs,’ Pkm2 up-regulation was not
reported [19,47]. For this reason, examining the relevance of miR-
122 in stem and cancer cells of human origin helps elucidate the
important tumor suppressor potential of this miRNA during the
differentiation process of hESCs into quiescent hepatocytes. Such
information may also provide a useful tool as a biomarker to
evaluate the safety and efficacy of hepatic derivatives of hESCs in
an in vitro differentiation culture system. Furthermore, studies like
this would be helpful for exploring additional avenues through
Figure 6. Methylation analysis of the genomic region upstream of miR-122 using ChIP-chip and bisulfite treatment. (A) High
resolution map of RNAPII and 5-MeC binding sites on ChIP samples of hESCs, hPHs and Hep3B. The horizontal bar on the top of the figure indicates
the genomic positions on chromosome 18, and the location of the mature miR-122 sequence in the genome is boxed in yellow. The predicted
promoter sequence of miR-122 (Figure S4) is indicated above the horizontal bar with the genomic positions. ChIP-chip data are listed below the
genomic position scale. Each vertical bar indicates the enrichment of a single probe as a log2 ratio value between the enriched ChIP sample and the
input sample. (B,C) The genomic regions that appear in Figure 6A to be bound by RNAPII in hPHs and methylated in hESCs and HCCs (18:54,264,000–
54,264,500 and 18:54,268,000–54,268,500) were verified by PCR. Arrows indicate the location of the primers, green bars indicate the amplified
products, and the product sizes are listed below the green bars. (D) Diagram showing the predicted promoter region of miR-122 and primers used for
amplification. The primers are indicated with letters A, B, C, D and colored in red. (E) PCR results showing that the methylation-specific primers
amplifies the predicted promoter region (D) in hESCs and HCCs, while unmethylation-specific primers amplifies the same region in hPHs after bisulfite
treatment. Control samples indicate hESCs, HCCs and hPHs that have not been bisulfite treated.
doi:10.1371/journal.pone.0027740.g006
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designing of early prognostic tools and treatment strategies for
therapeutic intervention. Given the multifaceted role of miR-122
in the liver [16–27], it is likely that this miRNA suppresses genes
other than Pkm2 to modulate hESC self-renewal and HCC
proliferation. For example, studies have shown that Igf1r is a direct
target of miR-122, and may function as a mediator of HCC
proliferation [48] (Figure S5). Future challenge will be to further
elucidate the involvement of miR-122 as a regulator of hESC self-
renewal and HCC proliferation through direct translational
suppression of genes in addition to Pkm2, as well as the role of
various other differentiated cell-specific miRNAs that have yet to
be explored.
Materials and Methods
Cell culture and differentiation
Human ES cells. Human H9 ES cell line was obtained from
the WiCell Research Institute (WA09), and maintained as a
monolayer in 6-well (9.6 cm
2) plates on gamma irradiated MEF
feeder layers in Dulbecco’s modified Eagle’s medium/Ham’s F-12
medium (Invitrogen) supplemented with 20% KnockOut Serum
Replacement (Invitrogen), 4 ng/ml basic fibroblast growth factor
(Invitrogen), 1 mM nonessential amino acids (Invitrogen), 2 mM
L-Glutamine (Invitrogen), 100 u/ml penicillin/streptomycin
(Invitrogen), and 0.55 mM 2-mercaptoethanol (Invitrogen).
Cultures were passaged after collagenase treatment at a ratio of
1:3 to 1:6 every 4–6 days. Feeder-independent cultures of hESCs
were maintained on matrigel (BD Biosciences) coated 6-well
plates, in MEF conditioned medium. Induction of hESCs to
definitive endoderm was initiated when hESC cultures were 75%–
85% confluent, at which time they were washed with phosphate
buffered saline (PBS) without calcium and magnesium
(Invitrogen), and cultured in RPMI medium (Invitrogen)
supplemented with 1XB27 (Invitrogen), 1 mM sodium butyrate
(NaB) (Sigma Aldrich), 2 mM L-Glutamine, 100 u/ml penicilline/
streptomycin, 0.5% KOSR, and 100 ng/ml Activin-A (R&D
Systems). Five days later, differentiation of definitive endoderm
into hepatic progenitor cell types was initiated by changing to
MDBK-MM medium (Sigma-Aldrich), supplemented with 2 mM
L-Glutamine, 100 u/ml penicilline/streptomycin, 10 ng/ml FGF-
4, and 10 ng/ml HGF. Three days later, differentiation and
Figure 7. Bisulfite sequencing analysis of the predicted promoter region of miR-122 in hESCs, HCCs and hPHs. (A) Bisulfite sequencing
PCR primer designed by the program MethPrimer using the predicted miR-122 promoter region as a template. (B) DNA sequence of the predicted
promoter region of miR-122 entered into the MethPrimer program. The output shows the primers used to amplify the template with red colored
arrows, the region amplified in green color, and the the cytocine (C) residue that would be converted into uracil if unmethylated is indicated with +.
(C) The table shows the position of the cytocine from (B) that would be converted into uracil in absence of methylation in the bisulfite treated
samples. Among the four cytocine positions, the bisulfite sequencing analysis showed that only the residues in hPHs were converted into uracil.
doi:10.1371/journal.pone.0027740.g007
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Bullet Kit (Lonza). Human primary hepatocytes (hPHs) were
obtained from the Liver Tissue Procurement and Distribution
System at the University of Pittsburgh. Upon receiving the cells,
they were washed three times in PBS without calcium and
magnesium, and maintained in HCM Bullet Kit. Hepatocellular
carcinoma cells HepG2 and Hep3B cells (American Type Culture
Collection) were cultured per the manufacturer’s instructions.
mRNA and miRNA expression microarrays
mRNA arrays. RNA samples were isolated using the
Qiagen RNeasy Kit (Qiagen). Prior to array experiments, the
quality of the RNA samples were assayed using the Agilent
Systems Bioanalyzer 2100. The total RNA from each sample
was biotinylated and amplified for hybridization to Illumina
Sentrix Expression Beadchip HumanRef-8 v3.0. This array
platform consists of eight parallel strips, each strip composed of
24,500 probes from the NCBI refseq database (Build 36.2,
Release 22). Arrays were processed and scanned per the
manufacturer’s instruction, and analyzed using the BeadStudio
Software v3.0. All signals were normalized, log2-transformed,
and ranked according to the log2 v a l u e s .F o re a c hg e n e ,t h e
criterion for enrichment was set at a log2 value of 6.0 or higher.
Hierarchical clustering was performed with average linkage and
Pearson correlation. To generate the heatmap, values were
centered and normalized to a mean of 0 and a standard
deviation of 5. miRNA arrays miRNAs were prepared using the
mirVana miRNA Isolation Kit from Ambion (Ambion), and
purified and concentrated for small nucleic acids using
flashPAGE Fractionator and flashPAGE Reaction Clean-up
Kit (Ambion). Amine-modified nucleotides were added to the
miRNAs in the samples, and labeled with Cy3 fluorescent dye
per the manufacturer’s instructions (Ambion). Labeled miRNAs
were hybridized to Human miRNA Array v1.0 (Ambion)
containing 365 human miRNA probes. Processed arrays were
scanned at 10-um resolution using the GenePix 400B scanner
(Axon Instruments). Raw data were normalized, log2-
transformed, and ranked according to the log2 values. For
each miRNA, the criteria for enrichment was set at log2 value
of 6.0 or higher. All data is MIAME compliant, and the raw
data has been deposited at GEO under accession number
(GSE29907).
Figure 8. 59RACE promoter analysis of pri-miR-122. (A) The sequence shows the promoter region of pri-miR-122 as determined by 59RACE.
CAAT-box and TATA box are highlighted in red, and the TSS is indicated with an arrow. The primer used to amplify the 59RACE product is underlined.
The DNA sequence shows chr18:54,264,000–54,265,000 (NCBI36/hg18). (B) The primer used to determine the promoter region of pri-miR-122 using
59RACE. (C,F) Relative expression of miR-122 after treating the HepG2 and Hep3B cells with 5-Aza-29Deoxycytidine for 3 days. n=3; error bars
represent s.e.m. Student’s t-test results are indicated by (*) P,0.05 and (**) P,0.01 relative to the control. (F,G) Relative expression of Pkm2 after
treating the HepG2 and Hep3B cells with 5-Aza-29Deoxycytidine for 3 days. n=3; error bars represent s.e.m. Student’s t-test results are indicated by
(*) P,0.05 and (**) P,0.01 relative to the untreated control. (H) Images of HepG2 and Hep3B cells 3 days after treatment with 5-Aza-29-
Deoxycytidine.
doi:10.1371/journal.pone.0027740.g008
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Functional annotation clusterings were performed using the
DAVID Bioinformatics Resources 2008. Gene sets that were
common between HCCs and hESCs, and HCCs and hPHs, were
subjected to separate clustering analyses. Each gene set was
entered into DAVID’s functional annotation clustering tool,
which generated clusters of genes based on the similarity of the
functional terms assigned to each gene. The clusters were then
ranked according to the EASE scores of each term, and the top
ten highest ranked clusters were selected for analysis. Within each
cluster, the top five Gene Ontology terms with the lowest P values
were selected as representative functional terms. If redundant
terms were present (e.g., developmental process and cellular
developmental process) the term with higher P value was
eliminated.
Chromatin immunoprecipitation assays and amplicon
preparation
ChIP assays were performed as described at http://www.
genomecenter.ucdavis.edu/farnham. Briefly, for 5-Methylcytidine
(5-MeC) ChIPs, genomic DNA was extracted from 1610
7 cells of
each sample, sonicated to an average size of 800 bp using a
Bioruptor Sonicator (Diagenode), denatured, and incubated with
the mouse monoclonal 5-MeC antibody (Eurogentec). RNAPolII
ChIP was performed by cross-linking 1610
7 cells from each
sample with 1.5% formaldehyde, after which time, nuclear
extracts were prepared and chromatin was sonicated to an
average size of 800 bp and incubated with mouse monoclonal
RNA polymerase II antibody (Covance). For both 5-MeC and
RNAPolII assays, secondary rabbit anti-mouse IgG (MP Biomed-
icals) was used, and the nonspecific rabbit IgG (Alpha Diagnostics)
was used as a negative control. Immunoprecipitates were purified
(QIAquick PCR purification kit, Qiagen), and amplicons were
generated using the Sigma GenomePlex WGA2 Kit (Sigma-
Aldrich). PCR positive and negative primers were used for ChIP
samples and amplicons to confirm the validity of the final product.
Assay and analysis of ChIP-chip data
The miR-122 promoter array was custom designed by tiling
20 kb region upstream from the mature miR-122 DNA sequence
with 50-mer probes on 386K array platforms. Amplicons were
labeled, hybridized to the promoter arrays, scanned, and analyzed
for signal intensity of each probe by Roche-NimbleGen Systems,
Inc. To confirm RNAPII binding and methylation, primers were
designed from 501 bp regions of chr18:54,264,000–54,264,500
and chr18:54,268,000–54,268,500, and RT-PCR was performed
using 1.0 ng of amplicons generated from RNAPII and 5-MeC
ChIP samples (hESCs, hPHs, HepG2, and Hep3B).
Figure 9. A model for miR-122 regulation of Pkm2. In hESCs and HCCs, hyper-methylation of the genomic region up-stream of miR-122 inhibits
transcription. In hPHs, an absence of methylation allows the binding of RNAPII and initiation of miR-122 transcription.
doi:10.1371/journal.pone.0027740.g009
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For mRNA RT-qPCR, total RNA was isolated using the
Qiagen RNeasy Kit (Qiagen), and SuperScript III RT-qPCR Kit
(Invitrogen) was used to synthesize cDNAs. For miRNA RT-
qPCR, miRNAs were isolated using mirVana miRNA Isolation
Kit (Ambion), and reverse transcribed into cDNAs using
miRCURY LNA First Strand cDNA Kit (Exiqon). For both
mRNAs and miRNAs, RT-qPCR mixture was prepared using
ABI TaqMan or Sybr Master Mix (ABI), and RT-qPCR were
performed on the ABI PRISM 7700 Sequence Detection System
(ABI). The comparative 22(DDCt) method was used to determine
the relative quantitative levels of mRNAs using GAPDH for
mRNA normalization and Exiqon’s Endogenous Control Primers
(Exiqon) for miRNA normalization, and expressed in values as
relative difference compared to the relevant controls.
Luciferase reporter construct and assay
The luciferase reporter was constructed by cloning into pMiR-
REPORT vector (Ambion) the target PKM2 sequences of miR-
122 downstream of the firefly luciferase gene and verified by
sequencing. The reporter plasmids were co-transfected with
20 pmol of precursor miR-122 molecules or mock precursor
miRNA molecules (Ambion) into 50,000 HepG2 cells in 24-well
plates using Lipofectamine 2000 (Invitrogen). Cells were lysed
36 hours later and processed for luciferase assay using the
Luciferase Reporter Assay System (Promega).
Lentiviral preparation and transduction
The production and titering of lentinvirus were carried out
according to protocols from Tronolab (http://tronolab.epfl.ch).
Western blot assay
Cells were lysed in RIPA buffer (Pierce). Twenty-five micro-
grams of cell lysates were analyzed on 12% SDS-PAGE. The
antibodies used were PKM2 (Cell Signaling), IGF1R (Cell
Signaling), GAPDH (Cell Signaling), anti-rabbit HRP-conjugated
secondary antibody (Cell Signaling).
Cell proliferation assay
50,000 HepG2 and Hep3B cells were grown on 24-well plates,
and transfected with 20 pmol of precursor miR-122 molecules or
mock precursor miRNA molecules (Ambion) using Lipofectamine
2000 (Invitrogen) 24 hours after initial plating of the cells. Cell
proliferation was measured 24 hours later using the Cell Titer Cell
Proliferation Assay (Promega) at 570 nm absorbance.
59 rapid amplification of cDNA end (RACE) analysis
59RACE was performed using the GeneRacer Kit (Invitrogen).
Bisulfite analysis
hESCs, HCCs and hPHs were treated with CpGenome Bisulfite
Modification Kit (Millipore). The genomic DNA was extracted
and PCR amplified. The PCR products were cloned into plasmids
for sequencing (Invitrogen).
5-Aza-29-Deoxycytidine treatment
100,000 HepG2 and Hep3B cells were grown on 6-well plates
and treated with 5 uM of 5-Aza-29-Deoxycytidine for 3 days.
Total RNA was extracted using the Qiagen RNeasy Kit (Qiagen),
and cDNAs were synthesized using SuperScript III RT-qPCR Kit
(Invitrogen).
Supporting Information
Figure S1 Genomic location and conservation of miR-
122 and Pkm2. (A) The location of miR-122 on chromosome 18
q arm is marked with a red bar. miR-122 is conserved in a large
fraction of vertebrates. (B) The location of the Pkm2 39UTR target
sequence on chromosome 15 q arm is marked with a red bar.
The target sequence predicted by MiRanda is located on
15:70,278,518–70,278,545 and the target sequence predicted by
RNAhybrid is located on 15:70,278,510–70,278,528. Pkm2 is
conserved in a large fraction of vertebrates. Data and images were
generated using the UCSC Genome Browser (genome.ucsc.edu).
(TIF)
Figure S2 Genomic location and conservation of miR-
122 and Pkm2. (A) The location of Pkm2 is indicated by a blue
bar, and the predicted hybridization site by miR-122 is indicated
by the purple bar. The target sequence is predicted by Target
Scan computational tool. The large boxed region shows that the
target sequence of miR-122 in the 39UTR of Pkm2 is conserved
among a large number of species. Data and images were generated
using the Target Scan computation prediction tool (www.
targetscan.org).
(TIF)
Figure S3 Reduction of endogenous Pkm2 expression by
miR-122 modulates cellular proliferation. (A) HepG2 and
Hep3B cells were transfected with siPkm2, precursor miR-122
molecules, or mock miRNA molecules. 24 hours (S1A) and
36 hours (S1B) post-transfection, five randomly chosen areas from
5 different wells in 24-well culture plates were stained with Hoecht
and counted for the number of nuclei. n=5; error bars represent
s.e.m.; Student’s t-test results are indicated by (*) P,0.05 and
(**) P,0.01 relative to the control.
(TIF)
Figure S4 Predicted transcription start site of verte-
brate RNAPII using Promoter2.0 and BDGP. (A) Genomic
region between chr18:54,263,500–54,269,000 was evaluated for
possible transcription start sequences using Promoter2.0 and
Berkeley Drosophila Genome Project (BDGP). DNA sequence
between chr18:54,263,800–54,265,000 yielded a highly likely
promoter sequence (B) at position 800. (C) Predicted promoter
sequences based on BDGP. Data and images were generated using
Promoter 2.0 (cbs.dtu.dk) and BDGP (www.fruitfly.org).
(TIF)
Figure S5 Overexpression of miR-122 is inversely
correlated with IGF1R in HepG2 and Hep3B. Western
blot assay of IGF1R in HepG2 and Hep3B overexpressing miR-
122.
(TIF)
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